✦ LIBER ✦

EORTC LCCG Phase II study of topotecan in combination with cisplatin as second line chemotherapy of sensitive and refractory small cell lung cancer (SCLC)

✍ Scribed by Ardizzoni, A; Manegold, C; Debruyne, C; Gaafar, R; Buchholz, E; Dussenne, S; Legrand, C; King, K; Giaccone, G

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

84 Phase II study of topotecan in refrac

✍ A. Ardizzoni; H.H. Hansen; P. Dombernowsky; S. Kaplan; P.E. Postmus; T. Gamucci; 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 159 KB

Phase II study of second-line gemcitabin

✍ Hoang, Tien; Kim, KyungMann; Jaslowski, Anthony; Koch, Paul; Beatty, Peter; McGo 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 168 KB

Randomised Phase II study of topotecan/c

✍ Gervais, R; Quoix, E; Mattson, K; Schramel, F.M; Rivière, A; Fields, S; Wheatley 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 105 KB

Second-line chemotherapy in small cell l

✍ G. P. Stathopoulos; Ch. Christodoulou; J. Stathopoulos; D. Skarlos; S. K. Rigato 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 192 KB

Gemcitabine and Paclitaxel Combination a

✍ Claudio Dazzi; Anna Cariello; Claudia Casanova; Alberto Verlicchi; Marco Montana 📂 Article 📅 2013 🏛 CIG Media Group, LP. 🌐 English ⚖ 327 KB

Phase II study of combined belotecan and

✍ Junshik Hong; Minkyu Jung; Yu Jin Kim; Sun Jin Sym; Sun Young Kyung; Jinny Park; 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 284 KB